|
Volumn 61, Issue 3, 2001, Pages 1045-1049
|
Tumor necrosis factor α sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR;
MATUZUMAB;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY EMD55900;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ADENOCARCINOMA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
CORRELATION FUNCTION;
HUMAN;
HUMAN CELL;
MOUSE;
MOUSE STRAIN;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SENSITIZATION;
SQUAMOUS CELL CARCINOMA;
TUMOR REGRESSION;
TUMOR VOLUME;
ADENOCARCINOMA;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BREAST NEOPLASMS;
CARCINOMA, SQUAMOUS CELL;
CELL DIVISION;
DRUG SYNERGISM;
FEMALE;
HUMANS;
LARYNGEAL NEOPLASMS;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
PHARYNGEAL NEOPLASMS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
TUMOR CELLS, CULTURED;
TUMOR NECROSIS FACTOR-ALPHA;
UTERINE CERVICAL NEOPLASMS;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0035116907
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (50)
|
References (23)
|